The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 124,862,422 | 5,991,479 | SH | SOLE | 5,991,479 | 0 | 0 | |||
ACELYRIN INC | COM | 00445A100 | 14,260,384 | 1,402,201 | SH | SOLE | 1,402,201 | 0 | 0 | |||
AEGLEA BIOTHERAPEUTICS INC | COM NEW ADDED | 00773J202 | 2,449,951 | 199,996 | SH | SOLE | 199,996 | 0 | 0 | |||
ALECTOR INC | COM | 014442107 | 26,286,431 | 4,056,548 | SH | SOLE | 4,056,548 | 0 | 0 | |||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 2,949,425 | 3,948,360 | SH | SOLE | 3,948,360 | 0 | 0 | |||
ALLAKOS INC | COM | 01671P100 | 1,700,003 | 748,900 | SH | SOLE | 748,900 | 0 | 0 | |||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 14,227,594 | 4,488,200 | SH | SOLE | 4,488,200 | 0 | 0 | |||
ANAPTYSBIO INC | COM | 032724106 | 135,077,591 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 414,630,636 | 10,899,859 | SH | SOLE | 10,899,859 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 27,864,300 | 732,500 | SH | Call | SOLE | 732,500 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 107,373,117 | 5,467,063 | SH | SOLE | 5,467,063 | 0 | 0 | |||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 20,987,583 | 6,995,861 | SH | SOLE | 6,995,861 | 0 | 0 | |||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 212,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 36,353,500 | 5,618,779 | SH | SOLE | 5,618,779 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 45,510,022 | 1,530,263 | SH | SOLE | 1,530,263 | 0 | 0 | |||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 12,630,960 | 993,000 | SH | SOLE | 993,000 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 20,016,002 | 3,493,194 | SH | SOLE | 3,493,194 | 0 | 0 | |||
GALAPAGOS NV | SPON ADR | 36315X101 | 198,879,059 | 5,756,268 | SH | SOLE | 5,756,268 | 0 | 0 | |||
GENERATION BIO CO | COM | 37148K100 | 7,757,626 | 2,046,867 | SH | SOLE | 2,046,867 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 7,657,932 | 9,195,404 | SH | SOLE | 9,195,404 | 0 | 0 | |||
GRAPHITE BIO INC | COM | 38870X104 | 21,175,346 | 8,538,446 | SH | SOLE | 8,538,446 | 0 | 0 | |||
HOOKIPA PHARMA INC | COM | 43906K100 | 2,830,535 | 4,595,024 | SH | SOLE | 4,595,024 | 0 | 0 | |||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 47,687,120 | 368,411 | SH | SOLE | 368,411 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 52,958,664 | 5,806,871 | SH | SOLE | 5,806,871 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 24,593,154 | 19,364,688 | SH | SOLE | 19,364,688 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 250,400,260 | 5,748,399 | SH | SOLE | 5,748,399 | 0 | 0 | |||
MORPHIC HLDG INC | COM | 61775R105 | 33,911,153 | 1,480,190 | SH | SOLE | 1,480,190 | 0 | 0 | |||
NEUMORA THERAPEUTICS INC. | COM ADDED | 640979100 | 29,228,160 | 2,071,450 | SH | SOLE | 2,071,450 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 616,651 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | |||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 6,886,004 | 6,435,518 | SH | SOLE | 6,435,518 | 0 | 0 | |||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 1,290,866 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | |||
NUVATION BIO INC | COM CL A | 67080N101 | 25,740,922 | 19,209,643 | SH | SOLE | 19,209,643 | 0 | 0 | |||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 20,679,311 | 3,418,068 | SH | SOLE | 3,418,068 | 0 | 0 | |||
OVID THERAPEUTICS INC | COM | 690469101 | 23,490,816 | 6,117,400 | SH | SOLE | 6,117,400 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 7,259,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
PRELUDE THERAPEUTICS INC | COM | 74065P101 | 3,576,527 | 1,157,452 | SH | SOLE | 1,157,452 | 0 | 0 | |||
PRIME MEDICINE INC | COM | 74168J101 | 5,724,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 3,874,021 | 2,980,016 | SH | SOLE | 2,980,016 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 558,941,510 | 11,584,280 | SH | SOLE | 11,584,280 | 0 | 0 | |||
RELAY THERAPEUTICS INC | COM | 75943R102 | 35,017,760 | 4,163,824 | SH | SOLE | 4,163,824 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 154,395,248 | 5,577,863 | SH | SOLE | 5,577,863 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 866,384 | 31,300 | SH | Call | SOLE | 31,300 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 80,000,009 | 3,460,208 | SH | SOLE | 3,460,208 | 0 | 0 | |||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 32,666 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | |||
TANGO THERAPEUTICS INC | COM | 87583X109 | 98,205,621 | 8,721,636 | SH | SOLE | 8,721,636 | 0 | 0 | |||
TEMPEST THERAPEUTICS INC | COM | 87978U108 | 283,676 | 931,000 | SH | SOLE | 931,000 | 0 | 0 | |||
THIRD HARMONIC BIO INC | COM | 88427A107 | 19,057,817 | 2,982,444 | SH | SOLE | 2,982,444 | 0 | 0 | |||
TSCAN THERAPEUTICS INC | COM | 89854M101 | 12,800,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | |||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 29,849,179 | 3,851,507 | SH | SOLE | 3,851,507 | 0 | 0 | |||
XENCOR INC | COM | 98401F105 | 106,442,697 | 5,282,516 | SH | SOLE | 5,282,516 | 0 | 0 | |||
ZYMEWORKS INC | COM | 98985Y108 | 85,193,579 | 13,437,473 | SH | SOLE | 13,437,473 | 0 | 0 |